Healthcare · Industry
Biotechnology - List & Prices (656 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Nkarta, Inc. | NKTX | $2.92 | $209.14M | — | |
| Oramed Pharmaceuticals Inc. | ORMP | $5.01 | $208.40M | 1.2 | 4.99% |
| NovaBridge Biosciences | NBP | $1.80 | $208.17M | — | |
| Alpha Cognition Inc. Common Stock | ACOG | $9.52 | $207.33M | — | |
| Precision BioSciences, Inc. | DTIL | $7.47 | $206.18M | — | |
| Cue Biopharma, Inc. Common Stock | CUE | $27.44 | $199.34M | — | |
| LENZ Therapeutics, Inc. | LENZ | $5.96 | $187.27M | — | |
| Jyong Biotech Ltd. | MENS | $2.39 | $181.71M | — | |
| Canton Strategic Holdings, Inc. | CNTN | $2.28 | $181.67M | — | |
| Korro Bio, Inc. | KRRO | $12.24 | $180.24M | — | |
| Immunic, Inc. | IMUX | $13.11 | $178.88M | — | |
| MediWound Ltd. | MDWD | $13.29 | $171.58M | — | |
| Caribou Biosciences, Inc. | CRBU | $1.57 | $168.32M | — | |
| Humacyte, Inc. | HUMA | $0.61 | $168.04M | — | |
| Molecular Partners AG | MOLN | $4.35 | $166.63M | — | |
| Spruce Biosciences, Inc. | SPRB | $57.93 | $166.49M | — | |
| Indaptus Therapeutics, Inc. | INDP | $1.22 | $162.56M | — | |
| Outlook Therapeutics, Inc. | OTLK | $0.67 | $161.74M | — | |
| Codexis, Inc. | CDXS | $1.46 | $159.88M | — | |
| Tenaya Therapeutics, Inc. | TNYA | $0.68 | $153.19M | — | |
| NRx Pharmaceuticals, Inc. | NRXP | $3.49 | $151.10M | — | |
| Milestone Pharmaceuticals Inc. | MIST | $1.20 | $149.40M | — | |
| Inovio Pharmaceuticals, Inc. | INO | $1.43 | $147.86M | — | |
| Biomea Fusion, Inc. | BMEA | $2.03 | $146.77M | — | |
| Mersana Therapeutics, Inc. | MRSN | $29.08 Jan 6, 2026 | $145.36M | — | |
| OnKure Therapeutics, Inc. | OKUR | $3.58 | $144.98M | — | |
| Unicycive Therapeutics, Inc. | UNCY | $5.16 | $141.35M | — | |
| Kazia Therapeutics Limited | KZIA | $12.31 | $140.67M | — | |
| Equillium, Inc. | EQ | $2.21 | $140.13M | — | |
| Helix BioPharma Corp. | HBP.TO | CA$1.80 | CA$137.48M | — | |
| TuHURA Biosciences, Inc. | HURA | $2.14 | $136.37M | — | |
| Vivani Medical, Inc. | VANI | $1.49 | $134.40M | — | |
| Conexeu Sciences Inc. | CNXU | $4.97 | $132.99M | — | |
| vTv Therapeutics Inc. | VTVT | $33.35 | $131.86M | — | |
| NeOnc Technologies Holdings, Inc. | NTHI | $5.03 | $130.46M | — | |
| Tiziana Life Sciences Ltd | TLSA | $1.02 | $129.80M | — | |
| enGene Therapeutics Inc. | ENGN | $1.82 | $121.92M | — | |
| Rani Therapeutics Holdings, Inc. | RANI | $0.87 | $121.59M | — | |
| Cibus, Inc. | CBUS | $1.59 | $121.52M | — | |
| Black Diamond Therapeutics, Inc. | BDTX | $2.12 | $121.48M | — | |
| Aardvark Therapeutics, Inc. | AARD | $5.38 | $117.74M | — | |
| Connect Biopharma Holdings Limited | CNTB | $1.84 | $115.87M | — | |
| Nautilus Biotechnology, Inc. | NAUT | $0.91 | $115.15M | — | |
| Cassava Sciences Inc | SAVA | $1.29 May 11, 2026 | $114.97M | — | |
| Repare Therapeutics Inc. | RPTX | $2.65 Jan 28, 2026 | $114.24M | — | |
| ProMIS Neurosciences, Inc. | PMN | $12.60 | $112.99M | — | |
| Coya Therapeutics, Inc. | COYA | $4.76 | $111.66M | — | |
| Fractyl Health, Inc. | GUTS | $0.70 | $110.88M | — | |
| Genelux Corporation | GNLX | $2.44 | $110.40M | — | |
| PolyPid Ltd. | PYPD | $5.39 | $109.48M | — |
Nkarta, Inc.
Healthcare / Biotechnology
- Market Cap
- $209.14M
- P/E
- unprofitable
Oramed Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $208.40M
- P/E
- 1.2
- Dividend Yield
- 4.99%
NovaBridge Biosciences
Healthcare / Biotechnology
- Market Cap
- $208.17M
- P/E
- unprofitable
Alpha Cognition Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $207.33M
- P/E
- unprofitable
Precision BioSciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $206.18M
- P/E
- unprofitable
Cue Biopharma, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $199.34M
- P/E
- unprofitable
LENZ Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $187.27M
- P/E
- unprofitable
Jyong Biotech Ltd.
Healthcare / Biotechnology
- Market Cap
- $181.71M
- P/E
- unprofitable
Canton Strategic Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $181.67M
- P/E
- unprofitable
Korro Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $180.24M
- P/E
- unprofitable
Immunic, Inc.
Healthcare / Biotechnology
- Market Cap
- $178.88M
- P/E
- unprofitable
MediWound Ltd.
Healthcare / Biotechnology
- Market Cap
- $171.58M
- P/E
- unprofitable
Caribou Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $168.32M
- P/E
- unprofitable
Humacyte, Inc.
Healthcare / Biotechnology
- Market Cap
- $168.04M
- P/E
- unprofitable
Molecular Partners AG
Healthcare / Biotechnology
- Market Cap
- $166.63M
- P/E
- unprofitable
Spruce Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $166.49M
- P/E
- unprofitable
Indaptus Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $162.56M
- P/E
- unprofitable
Outlook Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $161.74M
- P/E
- unprofitable
Codexis, Inc.
Healthcare / Biotechnology
- Market Cap
- $159.88M
- P/E
- unprofitable
Tenaya Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $153.19M
- P/E
- unprofitable
NRx Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $151.10M
- P/E
- unprofitable
Milestone Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $149.40M
- P/E
- unprofitable
Inovio Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $147.86M
- P/E
- unprofitable
Biomea Fusion, Inc.
Healthcare / Biotechnology
- Market Cap
- $146.77M
- P/E
- unprofitable
Mersana Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $145.36M
- P/E
- unprofitable
OnKure Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $144.98M
- P/E
- unprofitable
Unicycive Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $141.35M
- P/E
- unprofitable
Kazia Therapeutics Limited
Healthcare / Biotechnology
- Market Cap
- $140.67M
- P/E
- unprofitable
Equillium, Inc.
Healthcare / Biotechnology
- Market Cap
- $140.13M
- P/E
- unprofitable
Helix BioPharma Corp.
Healthcare / Biotechnology
- Market Cap
- CA$137.48M
- P/E
- unprofitable
TuHURA Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $136.37M
- P/E
- unprofitable
Vivani Medical, Inc.
Healthcare / Biotechnology
- Market Cap
- $134.40M
- P/E
- unprofitable
Conexeu Sciences Inc.
Healthcare / Biotechnology
- Market Cap
- $132.99M
- P/E
- unprofitable
vTv Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $131.86M
- P/E
- unprofitable
NeOnc Technologies Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $130.46M
- P/E
- unprofitable
Tiziana Life Sciences Ltd
Healthcare / Biotechnology
- Market Cap
- $129.80M
- P/E
- unprofitable
enGene Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $121.92M
- P/E
- unprofitable
Rani Therapeutics Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $121.59M
- P/E
- unprofitable
Cibus, Inc.
Healthcare / Biotechnology
- Market Cap
- $121.52M
- P/E
- unprofitable
Black Diamond Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $121.48M
- P/E
- unprofitable
Aardvark Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $117.74M
- P/E
- unprofitable
Connect Biopharma Holdings Limited
Healthcare / Biotechnology
- Market Cap
- $115.87M
- P/E
- unprofitable
Nautilus Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $115.15M
- P/E
- unprofitable
Cassava Sciences Inc
Healthcare / Biotechnology
- Market Cap
- $114.97M
- P/E
- unprofitable
Repare Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $114.24M
- P/E
- unprofitable
ProMIS Neurosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $112.99M
- P/E
- unprofitable
Coya Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $111.66M
- P/E
- unprofitable
Fractyl Health, Inc.
Healthcare / Biotechnology
- Market Cap
- $110.88M
- P/E
- unprofitable
Genelux Corporation
Healthcare / Biotechnology
- Market Cap
- $110.40M
- P/E
- unprofitable
PolyPid Ltd.
Healthcare / Biotechnology
- Market Cap
- $109.48M
- P/E
- unprofitable
Showing 351–400 of 656 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.